Market report
Cardiovascular drug tenders in Italy — market report, May 2026
Cardiovascular drug tenders in Italy in May 2026: 77 tenders published (-38% month on month, -13% year on year), estimated at €29,391,255 in total, and 44 contracts awarded (-53% month on month, -25% year on year), worth €22,026,954 (awarded value). Buyers with the most tenders: Azienda Ospedaliero-Universitaria Maggiore della Carita (13), Azienda Sanitaria Provinciale (11) and Azienda Sanitaria Locale TO3 (6); most contracts won: Rovi Biotech, S.R.L. (6), KEDRION S.P.A. (3) and Grifols Italia S.P.A. (3). On average 1.0 bids per contract; 100% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 77
- Contracts awarded
- 44
- Contract value awarded
- €22,026,954
- Bids per contract
- 1.0
The highlighted bar is May 2026. Hover a bar for its figure; the table below has every value.
| Figure | May 2026 | April 2026 | Change | May 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 77 | 125 | -38% | 89 | -13% |
| Estimated value | €29,391,255 | €39,940,515 | -26% | €21,725,176 | +35% |
| Buyers | 20 | 23 | -13% | 27 | -26% |
| Contracts awarded | 44 | 94 | -53% | 59 | -25% |
| Contract value (awarded) | €22,026,954 | €45,822,065 | -52% | €18,605,318 | +18% |
| Winners | 24 | 20 | +20% | 27 | -11% |
| Bids per contract | 1.0 | — | — | — | — |
| Single-bid contracts | 100% | — | — | — | — |
Buyers with the most tenders
Companies with the most contracts
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Cardiovascular and anticoagulant drugs
Questions and answers
- How many cardiovascular drug tenders were published in Italy in May 2026?
- 77 (by 20 buyers); for comparison, April 2026: 125, May 2025: 89.
- Who won the most cardiovascular drug tenders in Italy in May 2026?
- By number of contracts: Rovi Biotech, S.R.L. (6), KEDRION S.P.A. (3), Grifols Italia S.P.A. (3), Celltrion Healthcare Italy S.R.L. (2) and BAXTER S.P.A. (2); 24 companies won contracts in all.
- Which buyers published the most cardiovascular drug tenders in May 2026?
- Azienda Ospedaliero-Universitaria Maggiore della Carita (13), Azienda Sanitaria Provinciale (11), Azienda Sanitaria Locale TO3 (6), Azienda Socio Sanitaria Territoriale (ASST) Grande Ospedale Metropolitano Niguarda (6) and Azienda Ulss N. 1 Dolomiti (5).
- How competitive were cardiovascular drug tenders in Italy in May 2026?
- On average 1.0 bids per contract (6 contracts with a known number of bids); 100% of contracts had a single bid.
- What were the contracts worth in May 2026?
- €22,026,954 (awarded value, 44 contracts); median about €31,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.